AstraZeneca Seeks To Halt Looming Diabetes Drug Generics
AstraZeneca has asked an English court to block several generic-drug makers from imminently releasing variants of its billion-dollar diabetes treatment dapagliflozin ahead of a long-awaited judgment determining the validity of remaining...To view the full article, register now.
Already a subscriber? Click here to view full article